OncoLink Cancer Treatment and Resources

Treatment for Glioblastoma multiforme

Last Modified: September 26, 2003

Question

Dear OncoLink "Ask The Experts,"
My brother has Glioblastoma multiforme and my research shows that it does not react well to chemotherapy and that he has approximately 10 months (median) to live. Are there new medicines? bone marrow transplants? Is he better off to not go through the radiation and chemotherapy after affects? Please help. What would an expert do? 

Answer

, Josep Dalmau, MD, PhD Associate Professor of Neurology and Director of the Neuro-oncology Laboratory at the Abramson Cancer Center of the University of Pennsylvania responds:, responds:

Glioblastoma multiforme is one of the most aggressive malignant brain tumors of the adult. All studies show that treatment of the tumor improves the quality and quantity of life of these patients. Therefore, we recommend treatment for patients with this type of tumor. The conventional treatment includes: surgery, focal radiation therapy and chemotherapy (usually BCNU or Temozolamide). In general, patients tolerate these treatments well. An alternative approach is to look for clinical trials open at all major institutions. Patients that receive conventional treatment with surgery, radiation therapy and chemotherapy can also be enrolled in clinical trials if the tumor does not respond to the conventional treatment. The median survival of 10 months results from series comprising extensive number of patients. Some patients live shorter and others much longer than 10 months. In exceptional cases, patients get cured.

In our Institution, the experts in brain tumors comprise an extensive team of doctors and nurses that evaluate the clinical status of the patient and all the information (i.e., MRI or CAT scan films, and the pathology slides). After, this comprehensive review is completed (it takes 5-7 days) a final recommendation is made by the team of doctors.

OncoLink I wish u knew...

Ms. Schafer discusses the role of the chaplain and spirituality in cancer care. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS